Literature DB >> 2805429

Progressive ankylosis (ank/ank) in mice: an animal model of spondyloarthropathy. III. Proliferative spleen cell response to T cell mitogens.

H E Krug1, M L Mahowald, C Clark.   

Abstract

Murine progressive ankylosis is a spontaneous disorder of mice resulting from a homozygous recessive genetic defect (ank/ank) which produces an inflammatory arthritis of peripheral and axial joints eventually resulting in ankylosis of these joints. This disorder resembles the human spondyloarthropathies clinically, radiographically and histologically. Various studies in humans with spondyloarthropathies have described defects of cellular immunity but these results are conflicting. We measured the spleen cell response to mitogen in ank/ank mice and in normal littermates. The spleen cell response to the T cell mitogens phytohaemagglutinin and concanavalin A was decreased in ank/ank mice compared with their normal littermates. The response to the B cell mitogen lypopolysaccharide was normal in both ank/ank mice and normal littermates. Serum from ank/ank mice did not inhibit spleen cell responses to mitogen. Ank/ank spleen cells were not inhibitory of normal spleen cell responses to mitogens. Addition of irradiated normal spleen cells to ank/ank spleen cells did not restore the mitogen responses to normal. It is possible that the ank/ank gene results in the phenotypic expression of an abnormal or decreased cell product involved in T cell proliferation. Several recently described cytokines could be potential candidates for this product.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2805429      PMCID: PMC1534597     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Direct resorption of bone by human monocytes.

Authors:  C R Mundy; A J Altman; M D Gondek; J G Bandelin
Journal:  Science       Date:  1977-06-03       Impact factor: 47.728

2.  Diminished mixed lymphocyte response in ankylosing spondylitis.

Authors:  S L Wee; T J Daymond
Journal:  Tissue Antigens       Date:  1978-05

3.  Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals all with HL-A 27.

Authors:  B Nikbin; D A Brewerton; D C James; J R Hobbs
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

4.  Lymphocyte abnormalities in ankylosing spondylitis.

Authors:  P T Fan; P J Clements; D T Yu; G Opelz; R Bluestone
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

5.  Impaired cell-mediated immunity among HLA-B27 related rheumatoid variants responding to Yersinia antigen.

Authors:  K M Goebel; F D Goebel; R Baier
Journal:  J Clin Lab Immunol       Date:  1982-06

6.  Articular pathology of ankylosing spondylitis.

Authors:  J Ball
Journal:  Clin Orthop Relat Res       Date:  1979-09       Impact factor: 4.176

7.  Inhibition of mitogen stimulation of human peripheral blood leukocytes by Vibrio cholerae enterotoxin.

Authors:  D A Hart; R A Finkelstein
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

8.  Progressive ankylosis (ank/ank) in mice: an animal model of spondyloarthropathy. II. Light and electron microscopic findings.

Authors:  M L Mahowald; H Krug; P Halverson
Journal:  J Rheumatol       Date:  1989-01       Impact factor: 4.666

9.  Progressive ankylosis, a new skeletal mutation in the mouse.

Authors:  H O Sweet; M C Green
Journal:  J Hered       Date:  1981 Mar-Apr       Impact factor: 2.645

10.  Radiology of seronegative spondyloarthropathies.

Authors:  D Resnick
Journal:  Clin Orthop Relat Res       Date:  1979-09       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.